Dr. Amanda Fleming Marsch, MD

Dr. Marsch practices at AmeriPath - Pompano Beach (SW 30th Ave) in Pompano Beach, Florida.

Dr. Marsch's NPI, 1295025476, was assigned on April 9, 2011. Dr. Marsch graduated from University Of Kentucky College Of Medicine in 2011. Dr. Marsch's California license number on file is A136679.

Dr. Marsch's primary practice is AmeriPath - Pompano Beach (SW 30th Ave), at 895 Sw 30th Ave Ste 101, Pompano Beach, FL 33069. The practice phone is (954) 633-3770.

Dr. Marsch's primary practice is AmeriPath - Pompano Beach (SW 30th Ave) in Pompano Beach, Florida. The medical group on file is Palm Beach Dermatology. Dmand AI also links Dr. Marsch to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Marsch practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Marsch's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Marsch is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Marsch's licenses on file in 4 states: California, Florida, Colorado and Illinois.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, facial skin infection and hives among the conditions Dr. Marsch treats.

CMS data shows 8,859 Medicare services from Dr. Marsch across 25 procedure codes in 2024, for 1,089 Medicare patients. Medicare paid $403,125 for them. Every service was in an office.

CMS counts 1,089 Medicare patients who saw Dr. Marsch in 2024. The largest group is 65 to 74, with 487 patients. 75% of them have high cholesterol, and 68% have high blood pressure. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Marsch's median patient age at 72, with 54% women.

In 2024, Dr. Marsch wrote 1,839 Medicare Part D claims for 745 patients. 94% of them were for generic drugs. CMS names the drug for 1,701 of them, across 19 drugs with 11 or more claims each, at $286,481 in total drug cost. In 2023, CMS named 1,618 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Marsch for performance year 2024, reported as part of a group. Dr. Marsch accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 2,491 procedures of removal of skin lesions by Dr. Marsch, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 40 papers to Dr. Marsch, published from 2010 to 2022. 2020 was the busiest year, with 9. The most frequent topics are Skin Neoplasms, Dermatology and Immunohistochemistry. Dr. Marsch has published most often in Am J Dermatopathol. Dr. Marsch's most frequent co-authors are Brian Robert Hinds, MD, Min Deng, MD and Tanya Kaur Greywal, MD.

CMS Open Payments shows 174 general payments to Dr. Marsch from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 89% of the total. Abbvie Inc. paid the most, $748.

Dr. Marsch graduated from University Of Kentucky College Of Medicine in 2011.

Dr. Marsch is in network with 8 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.